Figures
Abstract
Purpose
The objective of this scoping review is to provide an overview of the available evidence on the effectiveness of web-based interventions for fear of cancer recurrence (FCR) and a discussion of drawbacks and possible improvements for web-based interventions identified in the reviewed studies. These steps fulfil the aim of this review, which is to offer suggestions for developing future web-based interventions based on the reviewed studies.
Methods
Five databases (PubMed, MEDLINE, EMBASE, SCOPUS and Web of Science) were searched. Original peer-reviewed articles, written in English, on web-based interventions for FCR were included for review. The data from the included studies was synthesised thematically.
Results
We included 34 papers reporting on 28 interventions. Most of the studies in the papers were quantitative and mixed quantitative studies with a qualitative element, e.g. an interview post-intervention. Interventions were most commonly trialled with women breast cancer patients. Top three countries where studies were conducted were USA, Australia and the Netherlands. The most common theoretical framework for interventions is cognitive behavioural therapy (CBT), followed by mindfulness-based and mixed CBT, mindfulness, acceptance and commitment therapy (ACT), relaxation approaches. FCR was the primary focus/measure in 19 Studies, in 9 studies FCR was a secondary/related outcome/measure. Overall, the evidence of efficacy of web-based interventions on FCR is mixed.
Conclusions
The existing research suggests several key points for producing more robust evidence about the effectiveness of web-based interventions for FCR. First, the studies suggest that it is a priority to better define eligibility criteria to proactively include people with higher levels of FCR. Second, there is a need for longer-term follow-up and outcome measuring period. Third, research examining the reasons for dropout from web-based interventions for FCR is critical to improve the effectiveness of web-based interventions. Fourth, while web-based interventions do not involve the costs of transportation, traveling time, space, equipment, cleaning, and other expenses, further cost utility analyses should be performed. Finally, future studies should assess how intervention accessibility, adherence, and effectiveness can be improved across different intervention designs, varying from intensive synchronous individual therapist-assisted web-based programme to blended designs combining the advantages of face-to-face and internet-based elements, to entirely self-managed programmes.
Implications for cancer survivors
Developing and evaluating more accessible FCR treatments have been identified among top international FCR research priorities (Shaw et al. 2021). While there is some evidence that web-based interventions can be as effective as face-to-face interventions, currently there is a dearth of systematic data about the ways in which the web-based modality specifically can enhance supportive care for FCR. Developing knowledge about effective web-based interventions has implications for cancer survivors as they can be presented with more accessible, low-cost and low-burden options for managing fear of cancer recurrence.
Citation: Zibaite S, Tripathee S, Moffat H, Elsberger B, Maclennan S (2024) Web-based interventions for fear of cancer recurrence: A scoping review with a focus on suggestions for the development and evaluation of future interventions. PLoS ONE 19(11): e0312769. https://doi.org/10.1371/journal.pone.0312769
Editor: Fatma Refaat Ahmed, University of Sharjah College of Health Sciences, UNITED ARAB EMIRATES
Received: June 20, 2024; Accepted: October 13, 2024; Published: November 8, 2024
Copyright: © 2024 Zibaite et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data to replicate the search is within the manuscript and its Supporting Information files.
Funding: This work is part of the grant from Friends of Anchor (Charity No SC025332 https://friendsofanchor.org/) (grant number RG16167), awarded to Dr. Maclennan, Dr. Moffat and Ms. Elsberger. Dr. Zibaite's post was funded by this grant. Dr. Tripathee did not receive any funding for her contribution to the article. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Fear of cancer recurrence (FCR) is defined as ‘the fear, worry or concern relating to the possibility that cancer will come back or progress’ [1]. Contemporary debates on FCR centre around determining the threshold of clinically significant FCR [2], differences between fear of cancer recurrence and fear of cancer progression [3], development and refinement of new scales for measuring FCR [4], and calling for specific clinical guidelines to manage FCR [5]. The call for guidelines specifies that there is a need to clarify whether FCR care should be matched to the severity of FCR (i.e., nonelevated, elevated, clinically elevated) [5].
Supportive care for FCR is the most commonly reported unmet need of cancer survivors [6, 7]. Despite reported high FCR prevalence within various groups (ranging from 39% to 97% in all continents and at all time points since diagnosis [8]), not enough is known about what works best, who would benefit most from FCR interventions and at what points in the cancer pathway to introduce them. There are a number of existing systematic and metareviews on web-based interventions for cancer care/aftercare [9–17] and on fear of cancer recurrence interventions more generally [18–21]. Several psychological interventions have been developed to reduce FCR with varying levels of effectiveness [10, 19]. However, more easily accessible synthesised evidence is needed to understand the role of online interventions as tools for clinicians to address FCR at pertinent timepoints for patients.
This has been especially pertinent since the Covid-19 pandemic laid bare the devastating effects of limited access to usual face-to-face care and social isolation on health anxiety [22, 23] and FCR [24]. As such, it engendered a push to utilise the technological capabilities for web-based interactivity to improve health service delivery and in turn, patient wellbeing [25–27] Developing and evaluating more accessible FCR treatments has been identified as top international FCR research priorities [28] and there is some evidence that online delivery of interventions may be as effective as face to face interaction [29]. However, it has been noted that simply converting proven face-to-face interventions to eHealth delivery does not exploit the full potential of technological options [12] This means that online interventions should be considered to have unique functionality, accessibility and longevity aspects that require closer investigation in order to enhance their applicability and benefits to people experiencing FCR.
Our review addresses a gap in literature in four ways: 1) it focuses exclusively on web-delivered interventions with a focus on FCR regardless of their psychological framework, 2) presents the existing evidence on outcomes of studies on interventions for various levels of FCR severity, 3) addresses not only which psychological frameworks for FCR interventions are effective for reduction of FCR but also whether there is any variability in the suitability of these psychological frameworks (e.g. CBT, ACT, mindfulness, etc.) for web-delivery; and 4) highlights the unique aspects of online intervention design and delivery that might enhance their applicability in supportive cancer care.
There are various definitions of the modes of delivery of the interventions that, broadly speaking, are not face-to-face, such as web-based, remote, digital, mHealth, eHealth, etc. Consistent definitions and continuous developments of classification of these interventions is increasingly important as these various modalities of interventions proliferate. Notable attempts are made to do so by Matis et al. [12] and Skrabal-Ross et al. [13]. The focus of our review is web-based interventions for FCR. Our definition of web-based interventions includes both synchronous (interactive meetings with nurses, physicians and peers) and asynchronous (pre-recorded talks, self-guided information websites, downloadable digital material, and smartphone apps) modes of delivery of the intervention via a digitally enabled and interned aided platform. We will include blended interventions (face-to-face sessions in combination with online delivery of material and/or telehealth sessions), with a view of discussing the added benefits and arising challenges of the digitally enabled component of the intervention.
Objectives
The objective of this scoping review is to provide an overview of the available evidence on the effectiveness of web-based interventions for FCR and a discussion of drawbacks and possible improvements for web-based interventions identified in the reviewed studies. This helps achieve the overall aim of the review which is to offer suggestions for developing future web-based interventions based on the reviewed studies
Methods
This is a scoping review conducted building on Arksey and O’Mally’s framework [30] to map the existing literature in a field of interest in terms of the volume, nature, and characteristics of the primary research. The main reviewer (SZ) performed an initial literature search on Pubmed, EMBASE, Web of Science, SCOPUS and MEDLINE databases in June 2024. Search terms associated with (1) FCR, combined with search terms associated with (2) cancer and (3) web-based intervention were used. The full search query can be found in the S1 Appendix. The reference lists of identified papers were also reviewed to identify further relevant sources that might have been omitted in the initial search. We report this review based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist, which can be found in S1 Checklist.
Inclusion and exclusion criteria
The search aimed to identify English language (1) peer-reviewed (2) literature reporting data from qualitative, quantitative and mixed-methods studies concerning the creation, delivery, or evaluation of a web-based intervention where reduction of FCR is a primary or secondary outcome measure (3) in people (both children and adults) who have been diagnosed with cancer. There was no restriction on cancer type, cancer stage, time since diagnosis, treatment type, or country/region of residence. We included papers based on primary and secondary analysis of research data. The literature search included studies published until June 2024, without a date cut-off for the earliest publication. This was suitable because of the relative recency of the emergence of interest in FCR as an onco-social phenomenon and the proliferation of digitally enabled interventions. All eligible articles were included in the review regardless of quality assessment rating as assessment of the quality of studies does not form part of the scoping review remit [30]. Excluded studies: not-peer reviewed, commentary, editorials and opinion paper, conference abstracts, study protocols, studies not in English language. The literature search flowchart can be found in Fig 1.
Data extraction and synthesis
Data was extracted using the SPIDER framework (sample, phenomenon of interest, design, evaluation and research type) [31]. For each study, the following information were extracted: author, year of publication, country, study design, sample size, cancer type, sex of participants, FCR measure, intervention features. A full text reading of each paper also allowed to pull out the key findings and messages regarding the value and pitfalls of using online mode of delivery for the interventions. The extracted data and overall text were analysed using a thematic analysis framework [32]. The final set of themes was reviewed and determined by all members of the research team.
Results
A total of 34 papers reporting on 28 different interventions are included in this review. All of them were identified first in the database searches and no new studies were identified in the manual reference list search.
Study characteristics
Of the included interventions, 15 were tested using a randomized controlled trial (RCT) design [19, 33–46] and 10 [47–56] were variations of development, pilot feasibility, usability and satisfaction studies. We also included one qualitative study about cancer survivors’ experience of participating in a virtual cognitive behavioural therapy-based telephone coaching program for fear of recurrence, a Canadian government funded BounceBack program [57]. One was a prospective observational study [58] based on a secondary analysis of trial data, and one was a quasi-experimental mixed-methods study [59]
Out of the 15 RCTs, twelve [33, 34, 37, 39–42, 44–46, 60, 61] had a no-intervention control (treatment as usual (TAU)). One out of these twelve studies, one [34] had an additional active intervention arm–face-to-face mindfulness-based cognitive therapy (MBCT) program. Two studies [35, 36] had a control condition of a slightly altered tested intervention. In FoRtitude trial [43],the control group received health management content.
Out of the 10 feasibility studies, [47, 49, 50, 52–56, 62] nine were a single-group, pretest-post-test pilot and one was a quasi-experimental effectiveness, acceptance and satisfaction study [59]. The aforementioned quasi-experimental study had a treatment as usual control arm but had to omit randomisation due to a small sample of participants.
Most of these studies were mixed quantitative studies with a qualitative element, e.g. an interview post-intervention. Most common countries for the studies were Netherlands (n = 6), Australia (n = 6) and USA (n = 5). The rest of the studies were based in Germany (n = 3), Taiwan (n = 1) and Japan (n = 2), UK (n = 1), Canada (n = 1), Switzerland (n = 1), China (n = 1), Denmark (n = 1). The characteristics of the included studies are presented in Table 1.
From the extracted data we identified six key themes that will be presented in this review: FCR measures used, considerations about target populations for web-based intervention; technological challenges; improving adherence; implementing interventions in existing pathways and choosing a theoretical framework for interventions. The following discussion is structured thematically.
Population characteristics
The population characteristics of the included studies are reported in Table 1. Most of the studies focused on people that had had cancer and were currently free of disease (n = 21). Seven [34, 35, 54, 55, 57–59] studies involve participants who are currently living with cancer. Most studies had female only participants (n = 15) followed by both male and female (n = 11) and two studies had only male participants [47, 48]. Most studies focused on patients with breast cancer (n = 12), followed by patients affected by various cancers (n = 10), testicular cancer (n = 2) and pediatric cancers (n = 1), lymphoma (n = 1), melanoma (n = 1), ovarian cancer (n = 1). All studies with breast cancer as their focus had only female participants. In studies where patients affected by various cancers were included, females were significantly overrepresented (76% of participants). Only one study [53] had equal numbers of male and female participants.
The language of the interventions depended on the patient population geographical location general spoken language. 13 interventions were in English [35, 36, 39, 42, 43, 47–49, 52–54, 57], Two were in Japanese [46, 50], 6 were in Dutch [33, 34, 37, 40, 44, 61]. Two were in Chinese [41, 45], four were in German [55, 56, 58, 59], one was in Danish [60].
FCR outcome
FCR was the primary focus/measure in 19 studies [35–40, 43, 45, 46, 50, 52, 54–57, 60–62], in 9 studies FCR was a secondary/related outcome/measure [33, 34, 41, 42, 44, 47, 49, 58, 59].
FCR measure
In terms of measuring fear of cancer recurrence, in our reviewed studies the FCRI scale was the most widely used (n = 8) [34, 37, 39, 42, 43, 57, 60, 61]. FCRI is a popular 42-item multi-dimensional FCR measure with strong psychometric properties. Also used were the brief FCR measures FCRI-SF (n = 3) [45, 51, 60]; FCRI—SF- NL (n = 1) [40]; Four item FCR scale (n = 1) [47]. FCRI and its short form were popular due to being measures created in USA and also prevalent in Australia, where most of the studies originated from. Other measures used were Concerns About Recurrence Scale (CARS) (n = 4) [35, 36, 49, 50]; Cancer Worry Scale (CWS) (n = 3) [33, 37, 44]; Japanese version of the Concern About Recurrence Scale (CARS-J) (n = 2) [46, 50]; Short form of the Fear of Progression and Relapse Questionnaire (FOP-SF) (n = 4) [54–56, 58], Two subscales of the Quality of Life of Adult Cancer Survivor Scale (QLACS) that specifically address frequently cited unmet needs for survivors: cancer-related fatigue and cancer-related concern or fear of recurrence were used in one study [52]. One study used the German version of the MAX-PC [59].
Perez et al. [53] paper on survivorship education plan for lymphoma survivors did not have a FCR specific measure assessing more general cancer-related uncertainty. Perez’s study was included in this review because the participants in Perez’s study raised the importance of fear of cancer recurrence being addressed and the interviews revealed how the remote delivery of a program may aid that.
Screening for eligibility
Only 7 reviewed studies used FCR measures for eligibility to participate in the studies. FoRtitude trial [43] included those with score 13 and over on the FCRI severity subscale. SWORD [37] included people scoring >14 on CWS, 6 month to 5 years after cancer treatment. BeMind [34] recruited people with a score of >11 on the Hospital Anxiety and Depression Scale (HADS). iCanADAPTEarly study [42] used HADS Total score of ≥6. Lichtenthal et al. [36] included breast cancer survivors who scored >3 on the CARS Overall Fear Index. ConquerFear-Group included those who scored ≥22 on the FCRI-SF [60].
Out of the studies that did not screen for FCR as part of eligibility criteria, only the following contained some note of justification about doing so. Heiniger et al. [47] piloted the e-TC intervention with testicular cancer survivors without significant psychological morbidity and later piloted an updated intervention (e-TC 2.0) [48] with participants with borderline/clinical levels of anxiety, depression, and/or FCR based on their pilot findings that the intervention is more beneficial for individuals who exhibit heightened FCR. In a study that has not screened for FCR [47], authors speculated that participants, exhibiting higher the clinical need for support were more likely to adhere to and complete the programme as well as report greater effects. The authors of the iConquerFear study [62] justified their lack of FCR screening because the FCR prevalence in their target populations (breast, colorectal, melanoma, prostate and ovarian cancers) was high. Otto et al. [35] noted that the level of wellbeing participants in their trial exhibited at the pre-assessment—low levels of anxiety, depression, and physical symptoms–was not necessarily representative of all early-stage breast cancer survivors. Related to this, Van Helmondt et al. [40] made a note that their CAREST trial intervention had ‘high ecological validity because not screening on level of FCR, the use of CAU (care as usual) and self‐help without extra help or emails reflected a realistic picture of web-based self‐help interventions’. This is a valid point for evaluating the status quo of the web-based self-help intervention landscape, but we argue it does not hold up against the aim of developing, trialling and evaluating future interventions to address unmet FCR needs. All in all, these results show that the included interventions have been tested with participants exhibiting a wide range of FCR severity.
Theoretical framework
Various theoretical frameworks were used for building the interventions. The most common theoretical framework for interventions was cognitive behavioural therapy (CBT) (n = 12) [33, 36, 37, 40, 42, 43, 50, 56, 57, 60, 62]. Second most common framework as mindfulness-based approaches (n = 4) [39, 45, 49, 55], such as mindfulness- based cognitive therapy [34]. Two studies were based on problem-solving therapy [46, 50] and behavioural activation [46], one study was a gratitude-eliciting intervention [35]. Four studies used mixed approaches: a combination of CBT, ACT, metacognitive therapy, mindfulness and relaxation [47, 48]; positive psychology, CBT and hope therapy [52]; mind and body, cognitive behavioural and positive psychology principles [53] The rest of the interventions reviewed built on more information-based approaches: FCR management information (n = 1) [54], a survivorship care plan (n = 1) [41]; group medical consultations in combination with a peer support app (n = 2) [44, 53].
Fear of recurrence intervention feasibility findings
All the interventions in this review evaluated in feasibility and usability studies have been deemed feasible and acceptable (n = 10).
Fear of cancer recurrence intervention effectiveness findings
Out of 15 included randomised trials, eleven showed effectiveness [33–37, 39, 41, 42, 45, 46, 60]. We cannot compere these as the studies used different measures. The sustainability of these effects was variable. Fang et al.’s online survivorship care plan [41] computerized application (SCP-A) was effective in decreasing the participants’ fear of recurrence after 12 months, and the effects of Luigjes-Huizer et. al’s primary care setting FCR intervention were visible after 10 months [61]. While Lichtenthal et al.’s cognitive bias modification intervention Attention and Interpretation Modification for Fear of Breast Cancer Recurrence (AIM-FBCR) [36] showed preliminary effectiveness in reducing FCR in survivors of breast cancer and levels of worry in women who received the intervention decreased from high-moderate to less than moderate, the CARS Health Worries subscale was the only one that remained clinically significantly changed after three months post-intervention [37]. Van den Berg et al. [33] reported that participants in BREATH programme together with care as usual showed a greater decrease in fear of cancer recurrence, fatigue, and general and cancer-related distress. SWORD study found to significantly reduce long-term (15 weeks) FCR [37, 38]. Compen et al. [34] found that compared with TAU, both MBCT and eMBCT significantly reduced fear of cancer recurrence. In the long term, the reduction of psychological distress was significantly higher in eMBCT than in MBCT [64]. Interestingly, Luigjes-Huizer et al. [61] found that while FCR severity decreased and participants were generally satisfied with the outcome, many participants still scored above the FCR cutoffs. The authors 13 (87%) and 16 cut‐offs (74%).
CAREST trial demonstrated no effect of CBT‐based online self‐help training to reduce FCR in breast cancer survivors compared with CAU (after 3 and 9 months) [40] and two years on [66]. The efficacy of FoRtitude, a CBT-based eHealth intervention specifically targeting FCR, could also not be proven effective by the authors because FCR decreased significantly across the attention control (health management content) as well [43]. Wagner et al. (2021) speculated that in this trial, eHealth delivery may be responsible for the lack of main effects between CBT and HMC (health management content) They believed that their eHealth platform might have diluted intervention effects. However, the authors do not provide the level of detail needed to justify this conclusion.
The feasibility and satisfaction studies in our review that showed the highest preliminary effectiveness were Onco-step [56], Kaiketsu-app [50, 58] and BounceBack [57]. The authors of these studies provided different accounts of their success. Imai et al. [50] developed their intervention specifically for smartphone use with a view of improving feasibility and portability, and to in part avoid the challenges associated with other remote web-delivered interventions–being time consuming and restrictive in terms of location (in the web-delivered case–desktop or laptop as not everyone carries them around). Seitz et al. [56] at the time had developed a broad scope therapist-guided intervention that would address post-traumatic stress symptoms, general anxiety, fear of recurrence, and promote the AYA survivors’ self-efficacy and independence, where the internet aspect also comes into play as it is a familiar mode of communication for young adults. Nguyen et al.’s [57] virtual CBT-based intervention responded to their identified need for an accessible, less-labour intensive for patients and less of a burden on the healthcare system mental health service and resource for post-treatment and survivorship cancer programs and clinics. This study also targeted and measured three psychosocial symptoms—depression, anxiety, and fear of recurrence.
On the other side of the spectrum of effectiveness, Pradhan et al.’s e-booklet [54], based on the Conquerfear program [67], did not significantly improve levels of FCR in women with ovarian cancer. No significant changes in FCR were reported in Mikolasek et al. study evaluating the feasibility and satisfaction of a mindfulness app [55]. Lange et al. [59] found that intervention participants reported poorer results for the primary and secondary outcomes in comparison to the control group patients at follow up. A secondary analysis of an RCT that showed no significant effects on anxiety, depression and fatigue [58], showed that there were small changes in the severity of FCR but because of the observational design feature of the study it was not possible to attribute these effects to the intervention.
Overall, while all the included interventions had been deemed feasible and acceptable, the evidence on preliminary effectiveness were mixed and requires further investigations in larger trials. The evidence from randomised control trials included in this review were more uniform but requires longer follow ups to examine the sustainability of the effects and further investigation into how the online modality specifically affects the intervention effectiveness outcomes.
Mode of delivery
The most popular mode of delivery across our reviewed studies was creating a dedicated website that hosted intervention material (n = 13) [33, 34, 39, 40, 42, 43, 47, 52, 56–58, 61, 62]. Two studies were tablet-based [44, 49]; two interventions were based on writing tasks [35, 56]; four studies reported development and evaluation of smartphone app-based interventions [41, 46, 50, 55]; four studies made use of telehealth group sessions [44, 45, 53, 60]; one study tested an online evidence-based psychoeducational booklet [54]; one study used individually tailored cognitive bias modification exercises [36]; one study utilised an online chat program [59]. The only intervention included in this review that still retained a significant face to face element was SWORD [37]. Three studies had phone communication as an additional element [43, 50, 57].
Intervention frequency and duration
The duration of the interventions reviewed ranged from a one-ff reading an online psychoeducational booklet with a follow-up one week later [54] to a 16-week program [42, 33]. The most common duration of the intervention was 6 weeks (n = 9) [35, 39, 45, 47–49, 52, 60] followed by 8 weeks (n = 4) [34, 46, 50, 53], 4 weeks (n = 3) [36, 43, 58], 10 weeks (n = 2) [55, 61], 12 weeks (n = 1) [37], 5 weeks (n = 2) [41, 59]; 16 weeks (n = 2) [33, 42]; 2 weeks (n = 1) [62]. Two studies provided a range instead of precise duration: 4–6 weeks (n = 1) [40] and 5–6 weeks (n = 1) [56]. 6 months was the expected time for BounceBack program completion [57]. My-GMC consisted of three group meetings over three months [44]. Wagner et al. [43] speculated that the FoRtitude trial did not yield evidence of efficacy of any of the FCR intervention components because of the low intensity and duration of the intervention (2 didactic lessons and a tool to use over 4 weeks). The CAREST [40] trial with 4–6 weeks required to complete all modules also did not report positive results. It had been suggested that longer duration of intervention would be more beneficial to patients with higher levels of FCR [10] however there was no consensus on the optimal duration and frequency of web-based interventions.
Target groups for FCR interventions
In those interventions included in our review where participants were affected by various cancers, it was often claimed that the intervention content was relevant to all cancer survivors regardless of the type of cancer [34, 52, 62]. However, the burden of FCR might be higher in some survivor cohorts, e.g. those dealing with more aggressive, more commonly recurring cancers, such as lymphoma [53], or among younger people [56]. ‘Those trials that involved specific age populations (i.e. pediatric cancers), or specific cancer types (i.e. breast cancer, testicular cancer) had developed these interventions to address specific pertinent concerns for these populations, such as intimacy, aesthetics. However, across these studies it was acknowledged that the content can be easily tailored for other cancer populations, or adapted to be used across all cancers.
Nevertheless, sharing the same lived experience also helps build rapport and a sense of group connection. Thus, it is worth considering how can the interventions be tailored to respond to these specific needs as accurately as possible. Seitz et al. [56] speculated that the treatment protocol was too structured for the youngest pediatric cancer survivors participating as all of the non-completers were significantly younger than participants fully completing the intervention. The authors also considered that the young adults might have missed the more lay and open communication or the informal interaction with peers. Smith et al. [62] argued that internet-based interventions may be particularly applicable to FCR because younger age is associated with higher FCR and web-based self-management acceptability. However, older age was associated with greater iConquerFear engagement [51], which was consistent with Cillessen et al.’s [64] findings that old age was not a predictor of engagement, but a predictor of uptake. Increased digital literacy of older adults supports the relevance of web-based interventions for all age groups.
Recruitment strategies
Only a minority of studies used one avenue of recruiting [33, 58, 60] and these were going through medical records [58, 60] and being referred onto trial by treatment team [33]. The other studies have used various combinations of recruitment strategies. Being referred onto trial by treatment team [33, 45, 55, 59, 67] was the most frequent employed strategy, followed by recruiting participants via social media [46, 55, 56, 61], cancer patient organisations [46, 54, 55, 61], reviewing medical records [57, 58, 60], exhibiting posters [46, 67], disseminating a leaflets [55]. Interventions where direct care team was involved in recruitment had better rates of adherence and completion, however that was also variable depending on the type of intervention (clinician managed or self-guided) so with this available evidence we are not able to currently establish a particular strong link between recruitment strategies and participant retention and completion.
We were able to observe that those interventions with less common cancer populations or more vulnerable participants employed more diverse recruitment strategies. For example, the former pediatric cancer patients for Onco-STEP [56] were recruited among participants in a former study on late psychosocial effects of adolescent cancer and by distributing information leaflets in hospitals, it was also advertised in newspapers and magazines, on Internet platforms, in broadcasts, and oral presentations at meetings of young adult cancer survivors. Parental consent was obligatory for applicants under 18 years of age, but there was otherwise no involvement from them.
Benefits and drawbacks of web-based interventions: self-guided or clinician-led?
The general benefits of the web-based delivery method reported in the reviewed studies were: own time management regarding access to self-guided materials; the ability to access the intervention (synchronous or asynchronous) from a familiar home setting; providing social validation and access to psychosocial support without the burden of travel, missing work and arranging and paying for childcare. Participant reported drawbacks varied, but most prevalent complaint was lack of contact and interaction with clinicians and for some, peers. Other drawbacks reported were: intervention perceived as impersonal [57], preference for printed workbooks over the website [37], higher dropout rates [34], technical improvements like keeping on top of the browser updates [47], scheduling challenges [53]
Contact with those who deliver and facilitate the intervention was an important aspect in intervention design in our reviewed studies. Qualified therapists delivered the intervention in ten reviewed studies, most often alongside the website self-guided materials [37, 43–45, 53, 56, 57, 59, 61]. Clinician supervision to a lesser extent (e.g. asynchronous communication, providing feedback, monitoring, tele coaching if required [34, 40, 42, 49, 56] was present in four studies [34, 40, 42, 49, 56]. Research teams were involved to provide prompts to participate in the intervention in two studies [35, 50]. One intervention was facilitated by trained peer-facilitators who were affected by cancer in some way [52]. 10 interventions were entirely self-guided. [33, 35, 36, 39–41, 47, 51, 54, 55]. The vast majority of the studies took place in a mental health setting and Luighes-Huizer et al. (2023) were the first to evaluate the impact of a psychological FCR intervention in primary care [61].
Reviewed articles often discussed the benefits and drawbacks of providing entirely self-managed interventions and self-guided resources. Self-guided/self-managed interventions were lauded for maximising scalability and reducing the time burden on both patients and medical staff members [50], but on the other hand, the amount of time required to complete self-managed interventions was lamented by participants as one of the drawbacks [47] especially in those that require daily commitment [34, 35, 43, 49, 50, 56, 57]. s It is important to note that in some interventions that were as a whole self-managed, some clinician supervision and contact has been retained [42, 49, 50, 66]. This is summarised in Table 2. Table 3 details the nature and extent of contact with clinicians in clinician delivered interventions for comparison.
Self-guided interventions generally had lower adherence than guided interventions which highlights the challenges of maintaining engagement in entirely self-guided interventions [62]. Smith et al. [62] noted that some professional facilitation, such as an orientation phone call or follow‐ups to troubleshoot difficulties, might be needed to optimise engagement and benefit, even if it limits scalability somewhat. Some contact with clinicians would also help to spot participants who would benefit from a more intensive FCR intervention. Several reviewed studies sent reminders to participants via email [39, 43, 50, 55] or phone message/call [40, 50,] to provide impetus to interact with the intervention and to provide encouragement about coping with FCR. In CAREST trial, reminders by phone resulted in a higher response than reminders by mail. Notifications of new uploaded content can reach all participants or relevant target groups and prolong the positive effects via remaining interactive [40]. The evidence on effectiveness of this approach is lacking and one review [12] has suggested a future study comparing the effectiveness of intervention with and without such reminders.
Real-world personal preference of participants was important in our reviewed studies, especially when offering and evaluating self-guided interventions. Compen et al. [34] reporting on their BeMind study noted that because one inclusion criterion for their study was the ability and willingness to attend both MBCT and eMBCT, the sampling frame was probably not representative of patients who would prefer eMBCT in clinical practice. Because treatment preference was often positively correlated with treatment outcome, the authors speculated that their RCT underestimated, rather than overestimated, the effects of eMBCT. This is a relevant note for future trial designs, also highlighting that further research is required to understand what drives some participants toward a digital intervention over a face-to-face one. Overall, the results from the BeMind study suggested that although the group-based setting was considered important for mindfulness-based interventions, self-guided eMBCT with limited teacher feedback was also effective because one’s self-efficacy and intrinsic motivation, as well as an attitude of self-discipline, were also important for treatment outcomes.
In the studies that utilised telecoaching, it was reported to increase intervention adherence and engagement, site use and retention [43], to help integrate what the survivors had learned, to provide clarification, and to prepare participants for future scenarios [57]. An initial one to one session with the therapist was employed in the ConquerFear-Group group-based intervention [60] to introduce the FCR model, and discuss possible individual vulnerability factors. The authors did not reflect on the influence of this, but a different study [63] had suggested that alliance building in web-based interventions may enhance engagement to treatment. Martin et al. [52] suggested that integrating a chat function was one way to give survivors the option to reach out to their peer network if desired, but not embedded in the programme as compulsory, which could alienate some potential participants.
Perez et. al. [53] observed a twofold benefit of remote group sessions. First, the changed setting of care by using a videoconference platform for some survivors allowed to avoid immediate negative associations with the site of cancer diagnosis and treatment which would otherwise have deterred them from visiting their cancer centre due to anxiety. Simultaneously, this allowed all survivors to receive support from providers within their own trusted institution, which might provide patients with a sense of care continuity. Thus, it was beneficial to both types of post-treatment patients and is important to consider when preference for a group setting is expressed [49].
Overall, there was a broad consensus amongst the studies that entirely self-managed web-based interventions were not as effective as those supplementing the web-based content with either a one-to-one follow up with nurses, coaches, doctors, access to peer forums, or taking place in a group format [51, 60, 68]. Many recommended adding professional support, like email contact or face‐to‐face assistance to future web-based interventions for FCR.
Adherence to interventions: rationale and technological capabilities
Higher adherence to web-based interventions had been found to be associated with better outcomes [69], however the evidence in our reviewed studies is mixed. In the FoRtitude study, higher use of the site was associated with greater reduction in FCR, however in the ConquerFear-Group study [60], the number of sessions attended and amount of homework completed were not associated with changes in FCR. hence it is important to ensure that the digitally enabled modality of FCR interventions is not affecting this aspect of the interventions negatively. Matis et al. [12] hypothesised that attrition rate of patients with cancer may be higher in web-based mindfulness-based programs than in face-to-face programs. Where addressed, the adherence and finishing rates in our reviewed studies varied: 44% in BREATH study [33], ‘about half’ in BeMind study [64], 70% in AIM-FBCR [32], 83% in MindOnline [36]. 50% in iHOPE intervention [52]. Peng et al. [45] speculated that the very low dropout rate from their study (three people out of 60) was partially due to a user-friendly app accompanying the web-based group sessions. These overall positive findings contrast with what Lange et al.’s [59] reported about their web-based chat program for prostate cancer patients: only 18 patients (5%) participated in the intervention group till follow-up. The mean age of participants in this study was 60.5 which was the oldest among the reviewed studies, but inferring that these low engagement results were due to lower digital literacy of older participants is not possible. Relevant to this review was Heiniger et al.’s [47] observation that completion rates may not be a good indicator of programme acceptability and feasibility because users of web-based interventions may prioritise accessing only information deemed immediately and personally relevant. Hence, e-TC 2.0, an updated version of e-TC had been made publicly accessible at any time without screening and compulsory modules [48]. This might be a suitable approach to increase engagement in cohorts that are traditionally less likely to take part in various interventions, such as males [47, 59].
One valuable technological capability of web-based interventions is the ability to track website usage [51] and it has been utilised in a small number of our reviewed studies, tracking a number of logins [43], spent using the app [48]. However, some aspects of intervention content were not possible to track, such as meditation practice [39, 64] and were based on self-report, which cannot be held to be objectively accurate. As meditation is an important aspect of any mindfulness intervention, this is an important point for future research on not only mindfulness-based online interventions for FCR, but for the observable and recordable aspects of web-based interventions at large. The ability to personalise some aspects of interface of web-based FCR interventions was touched on in some of our reviewed studies [41, 44] and might provide added benefit, such as increase in exercise completion rates [55]. Also, including personal stories of people with a similar experience can be a way of promoting shared understanding, connectedness and normality [47].
Longevity of accessibility of resources
Our reviewed studies revealed that the accessibility of intervention materials after the program ends could affect the effectiveness of the intervention. Smith et al. [62] noted that they had originally intended to release iConquerFear website modules every 1 to 2 weeks to encourage skill practice and consolidation, but participants claimed they might disengage if unable to progress at their own pace. While accessing the programs at one’s own pace and convenience was one of the reported attractive features of self-managed web-based interventions there are also several significant limitations to consider. For example, in the BREATH trial [33] attempting to maintain or improve adherence each week, new materials were released periodically, accompanied by standard e-mail reminders. Access to BREATH website was withdrawn after the end of the intervention at 16 weeks which contributed to loss of long-term improvements in psychological distress and FCR. FoRtitude trial [43] also denied access to the FoRtitude website after 4 weeks which, authors speculated, might have been a significant factor for their negative study findings. On the contrary, Fang et al. [41] argued that their positive outcomes, especially the significant decrease in FCR at the 12-month follow-up, might have been substantiated by the fact that their app continued to provide new information during the follow-up period. Overall, the reviewed studies suggested that lasting access to the resources and the ability to actively interact with the content after the intervention concludes was important for web-based interventions that seek to reduce FCR beyond the trial period [51].
Technical difficulties
Interestingly, only three studies included in our review reported directly on technical difficulties encountered by participants [36, 50, 53], most often access and navigation issues. As many of the studies noted that their sample included populations of relatively high level of education, comments on digital poverty were overall lacking, merely relegated to a limitations section that the sample was not representative of general population. Lack of internet access [40] and access to smartphones [55] were mentioned as problems for rec. Imai et al. [50] drew attention to more rarely addressed aspects of computer, tablet or smartphone-based interventions: increased sleep disturbance, activity reduction, visual loss and bumping into something. Some of these and similar effects are hard to observe and measure. Otherwise, most studies presented recommendations for improvement from participants as they related to the content and presentation of the interventions. These were varied: the need for more resources on lifestyle and family support [51]; more straightforward navigation pathways [51] the need to stay on top of browser upgrades (Heiniger et al. 2017); having a wider representation of cancer survivors in the intervention material to increase relatability [51], creating more mobile friendly websites [51] or mobile apps with a user friendly, visually appealing interface [36].
Transition to pathways/implementation to care
Only a small number of our reviewed studies had specific comments on this subject. e-TC study [47] included men who had completed treatment for testicular cancer, but the participant feedback was that having access to such an intervention earlier in the illness trajectory would be of greater benefit. iConquerFear [62] participants felt it would be best to offer iConquerFear at completion of active hospital‐based treatment, when decreasing levels of contact with the health system would result in people becoming more fearful. Referral or endorsement from a trusted health professional or organisation might increase uptake and engagement, but the authors noted that more research was needed on how best to disseminate web-based interventions. Indeed, van Helmondt et al. found that recruitment of patients by oncology nurses to the CAREST trial resulted in a higher response than recruitment by mail which indicates the important role usual healthcare practitioner endorsement might possibly play [40]. However, encouraging health care practitioners to refer to programs where they are available is as much of a challenge as making programs available post-evaluation [62]. iCanAdapt-Early [65] programme was placed in primary care pathway across the 12 participating cancer services but the number of referrals made was extremely low and none of the referrals were taken up. Only over a quarter of self-referrals made were within the cut off point for screening for eligibility. In contrast, one study on an intervention in primary care setting [61] used self-referral their recruitment strategy and found that, while the intervention had been designed for patients with moderate FCR, 53% of the group started with high FCR (FCRI-SF ≥22). The same authors have concluded that their FCR intervention in the primary care setting could be sufficient for many patients, especially if there are waiting lists for specialised care. However, for other patients (e.g. those with childhood trauma or other complex needs) it may be better to start with specialised care from the beginning. Thus, the questions about the most suitable strategies of increasing uptake of FCR interventions and during which points in survivorship journeys to introduce them [12] persist.
Discussion: Knowledge gaps and future directions
Collectively, the reviewed studies, systematic reviews and metareviews on web-based interventions agree that such interventions have potential but require more rigorous, sufficiently sampled trials with larger sample sizes to confirm effectiveness [13, 20]. The reviewed studies also suggested a need for longer term follow-up and outcome measuring period, better defined trial eligibility criteria, more diverse samples regarding sex, education, degrees of digital literacy, income, culture, language and cancer type [51]. There was a concern across the studies that the web-based intervention participants represented a more educated, digitally literate stratum of society. Overall, the reviewed studies suggested that it should be a priority for future interventions for FCR to proactively screen survivors with higher levels of FCR to participate in trials in order to get a convincing account of effectiveness of the intervention in reducing FCR.
This review highlights the complexities regarding the benefits and drawbacks of entirely self-managed interventions. Some features of self-managed interventions, such as the individual nature and the asynchronous interaction were preferred by some patients over a digitally enabled group encounter, which means that the development and proliferation of them would have the potential to engage cancer survivors with lower social skills or anxiety in social settings. The consensus across reviewed studies is that future studies should assess how intervention accessibility, adherence, and effectiveness can be improved in different intervention designs, varying from intensive synchronous individual therapist-assisted web-based programme to blended designs combining the advantages of face-to-face and Internet-based elements, to entirely self-managed programmes. This would help understand the optimal degree of guidance needed and the role of therapeutic alliance [63] in web-based FCR interventions to maximise engagement while minimising cost. There would be value in considering in further research the value of structured psychotherapeutic approaches compared with on-demand accessible support and information tools not only in regard to different patient FCR levels but also in relation to the timepoint in the survivorship journey as the needs of the survivors change with time. Generally, having more robust evidence on which treatment formats provide best outcomes to the reduction of FCR would help influence the design decisions of remotely delivered interventions. While web-based interventions do not involve the costs of transportation, traveling time, space, equipment, cleaning, and other expenses and could be more cost effective, further cost utility analyses should be performed. For example, Lengacher et al. [49] noted that their mMBSR(BC) program had the potential to reach cancer survivors who may be economically disadvantaged and/or underserved to attend a regular MBSR class. However, mMBSR(BC) was delivered through the use of iPad and Lengacher in their paper had not made a note about the provision of these devices to survivors who were not likely to own them if they were economically disadvantaged and the costs involved if providing them. Visser et al. [44] noted that they provided specifically programmed iPads.
Web-based programs aiming to reduce FCR should attempt to make full use of the technological capabilities that allow to create highly usable, flexible, adaptable structures of content and interaction that can be tailored to cater to arising needs during different steps of the cancer journeys. The quality of future feasibility studies of web-based interventions would be improved if they reported in more depth the technological barriers to engagement and the measures taken to overcome them, as well as assessing the interventions through more digitally versatile delivery modes (i.e. application-based, or email/chat communication-aided [39]. Tracking participants’ online behaviour, exercise completion, meditation times, i.e. moving beyond the self-reports of participation, would provide invaluable information on the impact of and preferences for the various aspects for the web-based interventions, which could help to improve engagement, adherence and satisfaction. It would also be worth researching whether intermittent assessment increased adherence. Overall, the reviewed studies revealed that research examining the reasons for dropout would be critical in improving the efficacy of web-based interventions.
Generally, evidence on real world uptake of web-based interventions for FCR is lacking. One way to envisage where web-based interventions for FCR reduction might fit in was in a stepped care model for addressing FCR [54, 60, 62, 70]. Moderators examining the effects of age, education level, and treatment type could also lead to a deeper understanding of which participants would benefit more from such interventions [41]. Further research on how to maximise the uptake and utility of web-based interventions, including determining the optimal points of introducing such interventions in relation to disease trajectory, determining clear referral pathways to the intervention as well as links back to additional services is needed [62], as well as involvement of PPI and underserved populations to better understand the barriers and facilitators to uptake [71]. In addition, further studies could utilize recruitment strategies aimed at widening participation for participants from ethnic minorities and low-income backgrounds.
The decisions on what framework to use for the web-based FCR interventions in our reviewed studies were mainly based on citing that the chosen framework (CBT, ACT, mindfulness, hope theory, etc.) had empirical evidence of effectiveness of decreasing FCR or more generally of improving quality of life and other psychological symptoms in cancer survivors, such as depression or anxiety. One systematic review and meta analysis found the Internet-based mindfulness interventions had no significant effects on fear of cancer recurrence [72]. CBT-based approaches had the largest body of evidence of effectiveness. Generally, the rationale for the included papers was to evaluate whether a web-based intervention based on selected psychological framework was feasible. Hence, from this review it is hard to claim that one psychological framework holds the supremacy over others in tackling FCR. However, what we discovered was that the choice of content of the interventions depended on the intended level of engagement and mode of delivery, e.g. if the intervention was a self-guided app as an addition to standard care, then it appeared that strategies that emphasise individual practice and are based on providing information, such as mindfulness-based or a survivorship plan content would be most suitable; for a clinician-guided course–cognitive and behavioural approaches, such as CBT or ACT might be more suitable as their therapeutic effects are also reliant on group or therapist-patient dynamics. The selection of synchronous vs asynchronous mode of delivery (or a combination of both) would also be influenced by the selected psychological framework.
Study limitations
This review included only articles written in English and did not consider grey literature, such as doctoral dissertations, thus not all relevant publications might have been included. Another limitation is that the data was searched, extracted and analysed by one reviewer (SZ). However, the search can be reproduced using the search terms, hence is robust enough. The narrative approach to systematising data is reliant on somewhat subjective decisions on what is included in the narrative. However, this fits with the nature of aims of scoping reviews and we do feel that this narrative will be a helpful tool for any readers looking for an easily readable synthesis of existing knowledge about what works and doesn’t work regarding web-based interventions for FCR.
Conclusion and future directions
Effective FCR treatments need to reflect the multi-dimensional nature of FCR. The studies reviewed here and those being currently trialled [73–78] are based on different psychological frameworks and modes of delivery and provide insight into long lasting, reusable, less labour intensive FCR interventions that can be dotted across various points of survivorship journeys. The exact combinations and ‘doses’ of these different interventions to deliver optimal results are unclear at the moment and will also vary from individual to individual. The continuously growing body of evidence of web-based interventions has the potential to populate the psychosocial cancer care landscape with well-rounded responses to FCR as an unmet cancer survivorship need.
The papers included in this review suggested several key points for future research on web-based interventions for FCR. First, the studies suggested a need for longer term follow-up and post-intervention outcome measuring period and better-defined trial eligibility criteria. They highlighted that it is a priority for interventions for FCR to proactively screen survivors with higher levels of FCR to participate in trials in order to get a convincing composite view of effectiveness of the intervention in reducing FCR. Second, more research examining the reasons for dropout is critical to improve the effectiveness of web-based interventions. Third, while web-based interventions do not involve the costs of transportation, traveling time, space, equipment, cleaning, and other expenses and could be more cost effective, further cost utility analyses should be performed. Fourth, allowing the participants to maintain access to the intervention materials and more so, updating it intermittently after the intervention trial concludes, has a great effect on long-term FCR outcomes. Finally, future studies should assess how intervention accessibility, adherence, and effectiveness can be improved across different intervention designs, varying from intensive synchronous individual therapist-assisted web-based programme to blended designs combining the advantages of face-to-face and Internet-based elements, to entirely self-managed programmes.
Digital interventions have an important and unique capacity to remain accessible, to be constantly updated and evolved without excessive efforts and costs. Overall, there is a much work to be done but also much to be excited about the existing scholarly consensus that web-based interventions have the potential to become a significant tool in onco-psychological care.
References
- 1. on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees, Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016 Aug;24(8):3265–8. pmid:27169703
- 2. Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G, et al. Identifying the key characteristics of clinical fear of cancer recurrence: An international Delphi study. Psychooncology. 2020 Feb;29(2):430–6. pmid:31713279
- 3. Coutts‐Bain D, Sharpe L, Pradhan P, Russell H, Heathcote LC, Costa D. Are fear of cancer recurrence and fear of progression equivalent constructs? Psychooncology. 2022 Aug;31(8):1381–9. pmid:35470502
- 4. Humphris GM, Watson E, Sharpe M, Ozakinci G. Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7. Health Qual Life Outcomes. 2018 Dec;16(1):30. pmid:29471823
- 5. Hall DL, Wagner LI, Lebel S, Smith A Ben , Bergerot CD, Park ER. Guidelines needed for the management of fear of cancer recurrence in adult survivors of cancer in the United States: A consensus statement. Cancer. 2024 Apr 17;cncr.35326. pmid:38630904
- 6. Butow P, Lebel S, Shaw J, Humphris G. Editorial: Uncertainty, Anxiety, and Fear of Cancer Recurrence. Front Psychol. 2021;12:811602. pmid:34956033
- 7. Bergerot CD, Philip EJ, Bergerot PG, Siddiq N, Tinianov S, Lustberg M. Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It? Am Soc Clin Oncol Educ Book. 2022 Jul;(42):18–27.
- 8. Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WWT, Lebel S, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology. 2022 Jun;31(6):879–92. pmid:35388525
- 9. McAlpine H, Joubert L, Martin-Sanchez F, Merolli M, Drummond KJ. A systematic review of types and efficacy of online interventions for cancer patients. Patient Educ Couns. 2015 Mar;98(3):283–95. pmid:25535016
- 10. Hall DL, Luberto CM, Philpotts LL, Song R, Park ER, Yeh GY. Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis. Psychooncology. 2018 Nov;27(11):2546–58. pmid:29744965
- 11. Triberti S, Savioni L, Sebri V, Pravettoni G. eHealth for improving quality of life in breast cancer patients: A systematic review. Cancer Treat Rev. 2019 Mar;74:1–14. pmid:30658289
- 12. Matis J, Svetlak M, Slezackova A, Svoboda M, Šumec R. Mindfulness-Based Programs for Patients With Cancer via eHealth and Mobile Health: Systematic Review and Synthesis of Quantitative Research. J Med Internet Res. 2020 Nov 16;22(11):e20709. pmid:33196452
- 13. Skrabal Ross X, Gunn KM, Olver I, Willems RA, Lechner L, Mesters I, et al. Online psychosocial interventions for posttreatment cancer survivors: an international evidence review and update. Curr Opin Support Palliat Care. 2020 Mar;14(1):40–50. pmid:31789944
- 14. Cincidda C, Pizzoli SFM, Pravettoni G. Remote Psychological Interventions for Fear of Cancer Recurrence: Scoping Review. JMIR Cancer. 2022 Jan 11;8(1):e29745. pmid:35014956
- 15. Koç Z, Kaplan E, Tanrıverdi D. The effectiveness of telehealth programs on the mental health of women with breast cancer: A systematic review. J Telemed Telecare. 2022 Feb 2;1357633X2110696. pmid:35108131
- 16. Fan M, Wang Y, Zheng L, Cui M, Zhou X, Liu Z. Effectiveness of online mindfulness-based interventions for cancer patients: a systematic review and meta-analysis. Jpn J Clin Oncol. 2023 Aug 11;hyad101. pmid:37567587
- 17. Yu S, Liu Y, Cao M, Tian Q, Xu M, Yu L, et al. Effectiveness of Internet-Based Cognitive Behavioral Therapy for Patients With Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Cancer Nurs [Internet]. 2023 Aug 8 [cited 2023 Aug 15]; Available from: https://journals.lww.com/10.1097/NCC.0000000000001274 pmid:37552227
- 18. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv Res Pract. 2013 Sep;7(3):300–22. pmid:23475398
- 19. Tauber NMO’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of Psychological Intervention on Fear of Cancer Recurrence: A Systematic Review and Meta-Analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2019 Nov 1;37(31):2899–915. pmid:31532725
- 20. Lyu MM, Siah RCJ, Lam ASL, Cheng KKF. The effect of psychological interventions on fear of cancer recurrence in breast cancer survivors: A systematic review and meta-analysis. J Adv Nurs. 2022 Oct;78(10):3069–82. pmid:35696315
- 21. Paperák P, Javůrková A, Raudenská J. Therapeutic intervention in fear of cancer recurrence in adult oncology patients: a systematic review. J Cancer Surviv [Internet]. 2022 Oct 28 [cited 2023 Aug 15]; Available from: https://link.springer.com/10.1007/s11764-022-01277-x pmid:36307611
- 22. Nekhlyudov L, Duijts S, Hudson SV, Jones JM, Keogh J, Love B, et al. Addressing the needs of cancer survivors during the COVID-19 pandemic. J Cancer Surviv. 2020 Oct;14(5):601–6. pmid:32335850
- 23. Ng DWL, Chan FHF, Barry TJ, Lam C, Chong CY, Kok HCS, et al. Psychological distress during the 2019 Coronavirus Disease (COVID ‐19) pandemic among cancer survivors and healthy controls. Psychooncology. 2020 Sep;29(9):1380–3. pmid:32497353
- 24. Kállay É, Medrea F, Dégi CL. On top of that all, now Covid-19, too. A scoping review of specificities and correlates of fear of cancer recurrence in breast cancer patients during COVID-19. The Breast. 2022 Apr;62:123–34.
- 25. Iyengar K, Mabrouk A, Jain VK, Venkatesan A, Vaishya R. Learning opportunities from COVID-19 and future effects on health care system. Diabetes Metab Syndr Clin Res Rev. 2020 Sep;14(5):943–6. pmid:32599533
- 26. Pierce BS, Perrin PB, Tyler CM, McKee GB, Watson JD. The COVID-19 telepsychology revolution: A national study of pandemic-based changes in U.S. mental health care delivery. Am Psychol. 2021 Jan;76(1):14–25. pmid:32816503
- 27. Park ER, Chiles C, Cinciripini PM, Foley KL, Fucito LM, Haas JS, et al. Impact of the COVID‐19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances. Cancer. 2021 Feb;127(3):334–8. pmid:33048350
- 28. Shaw J, Kamphuis H, Sharpe L, Lebel S, Smith AB, Hulbert-Williams N, et al. Setting an International Research Agenda for Fear of Cancer Recurrence: An Online Delphi Consensus Study. Front Psychol. 2021 Feb 22;12:596682. pmid:33692719
- 29. Kang N, Yu E. Is digital intervention for fear of cancer recurrence beneficial to cancer patients?: A systematic review and meta‐analysis. Psychooncology. 2023 Aug 12;pon.6199. pmid:37571918
- 30. Arksey HO’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005 Feb;8(1):19–32.
- 31. Cooke A, Smith D, Booth A. Beyond PICO: The SPIDER Tool for Qualitative Evidence Synthesis. Qual Health Res. 2012 Oct;22(10):1435–43. pmid:22829486
- 32.
Braun V, Clarke V. Thematic analysis. In: Cooper H, Camic PM, Long DL, Panter AT, Rindskopf D, Sher KJ, editors. APA handbook of research methods in psychology, Vol 2: Research designs: Quantitative, qualitative, neuropsychological, and biological [Internet]. Washington: American Psychological Association; 2012 [cited 2022 Sep 15]. p. 57–71. Available from: http://content.apa.org/books/13620-004
- 33. van den Berg SW, Gielissen MFM, Custers JAE, van der Graaf WTA, Ottevanger PB, Prins JB. BREATH: Web-Based Self-Management for Psychological Adjustment After Primary Breast Cancer–Results of a Multicenter Randomized Controlled Trial. J Clin Oncol Off J Am Soc Clin Oncol. 2015 Sep 1;33(25):2763–71. pmid:26169621
- 34. Compen F, Bisseling E, Schellekens M, Donders R, Carlson L, van der Lee M, et al. Face-to-Face and Internet-Based Mindfulness-Based Cognitive Therapy Compared With Treatment as Usual in Reducing Psychological Distress in Patients With Cancer: A Multicenter Randomized Controlled Trial. J Clin Oncol Off J Am Soc Clin Oncol. 2018 Aug 10;36(23):2413–21.
- 35. Otto AK, Szczesny EC, Soriano EC, Laurenceau JP, Siegel SD. Effects of a randomized gratitude intervention on death-related fear of recurrence in breast cancer survivors. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2016 Dec;35(12):1320–8. pmid:27513475
- 36. Lichtenthal WG, Corner GW, Slivjak ET, Roberts KE, Li Y, Breitbart W, et al. A pilot randomized controlled trial of cognitive bias modification to reduce fear of breast cancer recurrence. Cancer. 2017 Apr 15;123(8):1424–33. pmid:28055119
- 37. van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J. Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial. J Clin Oncol. 2017 Jul 1;35(19):2173–83. pmid:28471726
- 38. Burm R, Thewes B, Rodwell L, Kievit W, Speckens A, van de Wal M, et al. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial. BMC Cancer. 2019 Dec;19(1):462. pmid:31096934
- 39. Russell L, Ugalde A, Orellana L, Milne D, Krishnasamy M, Chambers R, et al. A pilot randomised controlled trial of an online mindfulness-based program for people diagnosed with melanoma. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2019 Jul;27(7):2735–46. pmid:30506103
- 40. van Helmondt SJ, van der Lee ML, van Woezik RAM, Lodder P, de Vries J. No effect of CBT-based online self-help training to reduce fear of cancer recurrence: First results of the CAREST multicenter randomized controlled trial. Psychooncology. 2020 Jan;29(1):86–97. pmid:31595627
- 41. Fang SY, Wang YL, Lu WH, Lee KT, Kuo YL, Fetzer SJ. Long-term effectiveness of an E-based survivorship care plan for breast cancer survivors: A quasi-experimental study. Patient Educ Couns. 2020 Mar;103(3):549–55. pmid:31558323
- 42. Murphy MJ, Newby JM, Butow P, Loughnan SA, Joubert AE, Kirsten L, et al. Randomised controlled trial of internet‐delivered cognitive behaviour therapy for clinical depression and/or anxiety in cancer survivors (iCanADAPT Early). Psychooncology. 2020 Jan;29(1):76–85. pmid:31659822
- 43. Wagner LI, Tooze JA, Hall DL, Levine BJ, Beaumont J, Duffecy J, et al. Targeted eHealth Intervention to Reduce Breast Cancer Survivors’ Fear of Recurrence: Results From the FoRtitude Randomized Trial. J Natl Cancer Inst. 2021 Nov 2;113(11):1495–505. pmid:34057469
- 44. Visser A, Prins JB, Jansen L, Radema SA, Schlooz MS, van Dalen T, et al. Group medical consultations (GMCs) and tablet-based online support group sessions in the follow-up of breast cancer: A multicenter randomized controlled trial. Breast Edinb Scotl. 2018 Aug;40:181–8. pmid:29906741
- 45. Peng L, Yang Y, Chen M, Xu C, Chen Y, Liu R, et al. Effects of an online mindfulness-based intervention on Fear of Cancer Recurrence and quality of life among Chinese breast cancer survivors. Complement Ther Clin Pract. 2022 Nov;49:101686. pmid:36347151
- 46. Akechi T, Yamaguchi T, Uchida M, Imai F, Momino K, Katsuki F, et al. Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study). J Clin Oncol. 2023 Feb 10;41(5):1069–78. pmid:36322882
- 47. Heiniger LE, Smith AB, Olver I, Grimison P, Klein B, Wootten A, et al. e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer. Eur J Cancer Care (Engl). 2017 Nov;26(6). pmid:28544085
- 48. Smith A ‘Ben’, Rincones O, Heiniger L, Grimison P, Tran B, Stockler MR, et al. Online psychological self-management intervention for testicular cancer survivors (e-TC 2.0): promising acceptability and preliminary efficacy, but limited feasibility. J Psychosoc Oncol Res Pract. 2020 Oct;2(3):e33.
- 49. Lengacher CA, Reich RR, Ramesar S, Alinat CB, Moscoso M, Cousin L, et al. Feasibility of the mobile mindfulness-based stress reduction for breast cancer (mMBSR(BC)) program for symptom improvement among breast cancer survivors. Psychooncology. 2018 Feb;27(2):524–31. pmid:28665541
- 50. Imai F, Momino K, Katsuki F, Horikoshi M, Furukawa TA, Kondo N, et al. Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study. Jpn J Clin Oncol. 2019 Jun 1;49(6):537–44. pmid:30793156
- 51. Smith A ‘Ben’, Bamgboje‐Ayodele A, Jegathees S, Butow P, Klein B, Salter M, et al. Feasibility and preliminary efficacy of iConquerFear: a self-guided digital intervention for fear of cancer recurrence. J Cancer Surviv [Internet]. 2022 Jul 25 [cited 2022 Sep 15]; Available from: https://link.springer.com/10.1007/s11764-022-01233-9
- 52. Martin F, Wright H, Moody L, Whiteman B, McGillion M, Clyne W, et al. Help to Overcome Problems Effectively for Cancer Survivors: Development and Evaluation of a Digital Self-Management Program. J Med Internet Res. 2020 May 19;22(5):e17824. pmid:32209529
- 53. Perez GK, Walsh EA, Quain K, Abramson JS, Park ER. A virtual resiliency program for lymphoma survivors: helping survivors cope with post-treatment challenges. Psychol Health. 2021 Nov;36(11):1352–67. pmid:33251861
- 54. Pradhan P, Sharpe L, Butow PN, Smith AB, Russell H. Is a Brief Online Booklet Sufficient to Reduce Fear of Cancer Recurrence or Progression in Women With Ovarian Cancer? Front Psychol. 2021;12:634136. pmid:33716902
- 55. Mikolasek M, Witt CM, Barth J. Effects and Implementation of a Mindfulness and Relaxation App for Patients With Cancer: Mixed Methods Feasibility Study. JMIR Cancer. 2021 Jan 13;7(1):e16785. pmid:33439132
- 56. Seitz DCM, Knaevelsrud C, Duran G, Waadt S, Goldbeck L. Internet-based psychotherapy in young adult survivors of pediatric cancer: feasibility and participants’ satisfaction. Cyberpsychology Behav Soc Netw. 2014 Sep;17(9):624–9. pmid:25167082
- 57. Nguyen P, Heisey R, Quenneville C, Goulbourne E, Khan R, Rinaldo E, et al. An examination of depression, anxiety, and fear of recurrence among cancer survivors who participated in a virtual cognitive behavioral therapy (CBT)-based telephone coaching program. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2022 Sep;30(9):7323–32.
- 58. Schlecht S, Neubert S, Meng K, Rabe A, Jentschke E. Changes of Symptoms of Anxiety, Depression, and Fatigue in Cancer Patients 3 Months after a Video-Based Intervention. Int J Environ Res Public Health. 2023 Oct 17;20(20):6933. pmid:37887671
- 59. Lange L, Fink J, Bleich C, Graefen M, Schulz H. Effectiveness, acceptance and satisfaction of guided chat groups in psychosocial aftercare for outpatients with prostate cancer after prostatectomy. Internet Interv. 2017 Sep;9:57–64. pmid:30135838
- 60. Tauber NMO’Toole MS, Jensen AB Butow PN, Thewes B, Elkjær E et al. ConquerFear‐Group: A randomized controlled trial of an online‐delivered group‐based psychological intervention for fear of cancer recurrence in breast cancer survivors. Psychooncology. 2023 Jul 25;pon.6193. pmid:37489745
- 61. Luigjes‐Huizer YL, Helsper CW, De Wit NJ, Van Der Lee ML. Effectiveness of a guided online primary care intervention for fear of cancer recurrence: A randomised controlled trial. Psychooncology. 2023 Dec;32(12):1839–47. pmid:37850876
- 62. Smith A “Ben”, Bamgboje‐Ayodele A, Butow P, Klein B, Turner J, Sharpe L, et al. Development and usability evaluation of an online self‐management intervention for fear of cancer recurrence (iConquerFear). Psychooncology. 2020 Jan;29(1):98–106.
- 63. Bisseling E, Cillessen L, Spinhoven P, Schellekens M, Compen F, van der Lee M, et al. Development of the Therapeutic Alliance and its Association With Internet-Based Mindfulness-Based Cognitive Therapy for Distressed Cancer Patients: Secondary Analysis of a Multicenter Randomized Controlled Trial. J Med Internet Res. 2019 Oct 18;21(10):e14065. pmid:31628791
- 64. Cillessen L, van de Ven MO, Compen FR, Bisseling EM, van der Lee ML, Speckens AE. Predictors and Effects of Usage of an Online Mindfulness Intervention for Distressed Cancer Patients: Usability Study. J Med Internet Res. 2020 Oct 2;22(10):e17526. pmid:33006567
- 65. Davies F, Harris M, Shaw J, Butow P, Newby J, Murphy M, et al. Uptake of an online psychological therapy program (iCanADAPT‐Early) when implemented within a clinical pathway in cancer care centres. Psychooncology. 2022 Feb;31(2):338–41. pmid:34519384
- 66. van Helmondt SJ, Lodder P, van Woezik R, de Vries J, van der Lee ML. CBT-based Online Self-help Training to Reduce Fear and Distress After Cancer (CAREST Randomized Trial): 24 Months Follow-up Using Latent Growth Models and Latent Class Analysis. Ann Behav Med. 2023 Apr 20;kaac078. pmid:37078920
- 67. Butow PN, Turner J, Gilchrist J, Sharpe L, Smith AB, Fardell JE, et al. Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence. J Clin Oncol Off J Am Soc Clin Oncol. 2017 Dec 20;35(36):4066–77. pmid:29095681
- 68. Beatty L, Binnion C. A Systematic Review of Predictors of, and Reasons for, Adherence to Online Psychological Interventions. Int J Behav Med. 2016 Dec;23(6):776–94. pmid:26957109
- 69. Couper MP, Alexander GL, Zhang N, Little RJ, Maddy N, Nowak MA, et al. Engagement and Retention: Measuring Breadth and Depth of Participant Use of an Online Intervention. J Med Internet Res. 2010 Nov 18;12(4):e52. pmid:21087922
- 70. Lynch FA, Katona L, Jefford M, Smith AB, Shaw J, Dhillon HM, et al. Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma. J Clin Med. 2020 Sep 14;9(9):2969. pmid:32937942
- 71.
NIHR (2020) Improving inclusion of under-served groups in clinical research: Guidance from the NIHR-INCLUDE project. [Internet]. UK: NIHR.; 2020 [cited 2022 Oct 25]. Available from: https://www.nihr.ac.uk/documents/improving-inclusion-of-under-served-groups-in-clinical-research-guidance-from-include-project/25435
- 72. Fan M, Wang Y, Zheng L, Cui M, Zhou X, Liu Z. Effectiveness of online mindfulness-based interventions for cancer patients: a systematic review and meta-analysis. Jpn J Clin Oncol. 2023 Nov 5;53(11):1068–76. pmid:37567587
- 73. Livingston PM, Russell L, Orellana L, Winter N, Jefford M, Girgis A, et al. Efficacy and cost-effectiveness of an online mindfulness program (MindOnLine) to reduce fear of recurrence among people with cancer: study protocol for a randomised controlled trial. BMJ Open. 2022 Jan;12(1):e057212. pmid:35022179
- 74. Lichtenthal W, Breitbart W. Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study [Internet]. ClinicalTrials.gov; 2012 [cited 2022 Sep 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT01517945
- 75. Leermakers L, Döking S, Thewes B, Braamse AMJ, Gielissen MFM, de Wilt JHW, et al. Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors. BMC Cancer. 2018 Dec;18(1):748. pmid:30021555
- 76. Döking S, Koulil SS van, Thewes B, Braamse AMJ, Custers A, Prins JB. Combined Face-to-Face and Online Cognitive-Behavioral Therapy for High Distress of Colorectal Cancer Survivors: A Case Study. Cogn Behav Pract. 2021 Feb;28(1):107–23.
- 77. Subnis UB, Farb NA, Piedalue KAL, Speca M, Lupichuk S, Tang PA, et al. A Smartphone App–Based Mindfulness Intervention for Cancer Survivors: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 May 11;9(5):e15178. pmid:32390591
- 78. Pal SK. App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer [Internet]. ClinicalTrials.gov; 2021 [cited 2022 Sep 20]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04788095